Wenliang Dong, Ph.D., MBA

Chief Executive officer (CEO)

Wen has over 15 years of experience in pharmaceutical development, having held leadership positions in operations, quality management, and business development. Wenliang worked at Sanquin Plasma Products BV as a Project Leader in the CMO division and as a member of the management team of Pharmaceutical Services. He holds a Ph.D. in Medical Microbiology from the University of Leiden, collaborating with the German Cancer Research Center in Heidelberg, Germany, and the International Agency for Research on Cancer in Lyon, France. Additionally, he earned an executive MBA degree (cum laude) from the RSM Erasmus University. Wen will lead the team in developing ORCA’s platform from breakthrough science to clinical success.